Covaxin (688136.SH) subsidiary GB19 injection I Phase clinical trial completes the first participant enrollment.

Zh tng cijng APP xn, k xng zh yo (688136.SH) fb gnggo, jnr, gngs qunz zgngs Shnzhn k xng yoy yuxin gngs zzh ynf de bxing BDCA2 (xu sh tzhung xbo kng yun 2) de chungxn yow "GB19 zhsh y" I q lngrn ynji chnggng wnchng shu l cny zh rz jyo. Gi ynji wi y xing zh zi pngg GB19 zhsh y zi zhnggu jinkng cny zh j xtngxng hngxn lngtng cny zh zhng gi yo de nqun xng, nit xng, yodidngl xu, yoxio xu tzhng de ynji.